加斯德明D通过中性粒细胞扩大炎症促进流感病毒诱导的死亡率

Samuel Speaks1, Matthew I McFadden1,2, Ashley Zani1,2

  • 1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH, USA.

Nature communications
|March 30, 2024
PubMed
概括

加斯德明D (GSDMD) 通过驱动有害的中性粒细胞反应,促进严重的流感. 阻止GSDMD可降低小鼠的肺炎和死亡率,这表明流感是一种新的治疗点.